Home | Discreedly

As the digital world continues to evolve, it's no surprise that today’s healthcare providers are more digitally savvy than ever. However, the analog methods used by pharma for HCP engagement, proved to be a hurdle that needed overcoming...

The pandemic expedited a change to the status quo and

DISCREEDLY will be a key partner for this transformational shift!

I've Read Enough, LET'S TALK!

SIGN UP FOR OUR NEWSLETTER

Services

Omnichannel Platform

dynamic omnichannel

HCP engagement platform

Streamlined Access To Medical Affairs

seamless connection to enable needs-based scientific exchange

Drug "meDISphere"

centralized data dissemination and tailored content delivery

SERVICES

Transform Your Medical Affairs Team

With Next-Gen Engagement Tools!

About

ABOUT US

Discreedly is a digital platform that will be available via both a web based application and also a mobile app. The platform will provide pharma companies with a resource for omnichannel engagement with HCPs as well as provide various reports and analytics to optimize engagement strategies.

Discreedly provides HCPs with access to information and resources (like on-demand MSLs), to receive the information they need and prescribe the right medication for their patients. Discreedly also allows HCPs to receive real-time updates on their frequently prescribed medications, to stay current on the newest data and improve their patient outcomes.

Testimonials

“MD's want more personalized engagement and tailored content. They increasingly expect pharma to demonstrate an understanding of their needs and interests”

BCG Survey
2021

Who is Discreedly for?

Discreedly is designed for use by all stakeholders within the Medical Affairs space of the pharmaceutical industry. This includes the Field Medical Teams (MSLs, Medical Advisors, Medical Managers, Field Medical Excellence etc.), Medical Information, Med Comms, Study and ISR Ops, Pubs & Med Ed, and HEOR. Discreedly was also created to bring medical affairs into the community healthcare setting and provide community HCPs with access to information and resources that has traditionally been focused on a KOL. It is increasingly more evident that a needs-based approach to engagement must be undertaken by pharma and having an omnichannel platform like Discreedly can facilitate this strategy.
Are you offering any pilots?

YES! Discreedly is actively looking for pharma partners to conduct operational pilots to see how our solutions can transform your medical affairs engagement. Contact us at info@discreedly.com to learn more about piloting.

FAQs